242 related articles for article (PubMed ID: 19661812)
1. Celastrol, a triterpene extracted from Tripterygium wilfordii Hook F, inhibits platelet activation.
Hu H; Straub A; Tian Z; Bassler N; Cheng J; Peter K
J Cardiovasc Pharmacol; 2009 Sep; 54(3):240-5. PubMed ID: 19661812
[TBL] [Abstract][Full Text] [Related]
2. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
3. Prasugrel 5 mg inhibits platelet P-selectin and GPIIb-IIIa expression in very elderly and non elderly: results from the GENERATIONS trial, a pharmacodynamic study in stable CAD patients.
Wagner H; Lood C; Borna C; Gidlöf O; Truedsson L; Brown P; Zhou C; Winters K; Jakubowski JA; Erlinge D
J Thromb Thrombolysis; 2016 Oct; 42(3):369-75. PubMed ID: 27165280
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
5. Celastrol induced DNA damage, cell cycle arrest, and apoptosis in human rheumatoid fibroblast-like synovial cells.
Xu Z; Wu G; Wei X; Chen X; Wang Y; Chen L
Am J Chin Med; 2013; 41(3):615-28. PubMed ID: 23711145
[TBL] [Abstract][Full Text] [Related]
6. Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology.
Hou W; Liu B; Xu H
Eur J Med Chem; 2020 Mar; 189():112081. PubMed ID: 31991334
[TBL] [Abstract][Full Text] [Related]
7. Aged garlic extract inhibits platelet activation by increasing intracellular cAMP and reducing the interaction of GPIIb/IIIa receptor with fibrinogen.
Allison GL; Lowe GM; Rahman K
Life Sci; 2012 Dec; 91(25-26):1275-80. PubMed ID: 23069586
[TBL] [Abstract][Full Text] [Related]
8. Effects of fibrinogen receptor antagonist GR144053F and aurintricarboxylic acid on platelet activation and degranulation.
Rozalski M; Boncler M; Golanski J; Watala C
Biochem Pharmacol; 2001 Nov; 62(10):1399-408. PubMed ID: 11709200
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new platelet glycoprotein IIb/IIIa antagonist, SR121566, on platelet activation, platelet-leukocyte interaction and thrombin generation.
Li N; Wallén NH; Savi P; Hérault JP; Herbert JM
Blood Coagul Fibrinolysis; 1998 Sep; 9(6):507-15. PubMed ID: 9819001
[TBL] [Abstract][Full Text] [Related]
10. Can the antiplatelet effects of cangrelor be reliably studied in mice under in vivo and in vitro conditions using flow cytometry?
Kassassir H; Siewiera K; Sychowski R; Watała C
Pharmacol Rep; 2013; 65(4):870-83. PubMed ID: 24145081
[TBL] [Abstract][Full Text] [Related]
11. Role of glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) in stimulation of secretion from platelet granules.
Naimushin YA; Mazurov AV
Biochemistry (Mosc); 2003 Feb; 68(2):209-16. PubMed ID: 12693968
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
Schneider DJ; Taatjes DJ; Sobel BE
Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
[TBL] [Abstract][Full Text] [Related]
13. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
14. Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parameters.
Klinkhardt U; Kirchmaier CM; Westrup D; Breddin HK; Mahnel R; Graff J; Hild M; Harder S
Thromb Res; 2000 Feb; 97(4):201-7. PubMed ID: 10674406
[TBL] [Abstract][Full Text] [Related]
15. Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications.
Holmes MB; Sobel BE; Howard DB; Schneider DJ
Thromb Res; 1999 Jul; 95(2):75-82. PubMed ID: 10418796
[TBL] [Abstract][Full Text] [Related]
16. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.
Yang H; Chen D; Cui QC; Yuan X; Dou QP
Cancer Res; 2006 May; 66(9):4758-65. PubMed ID: 16651429
[TBL] [Abstract][Full Text] [Related]
17. Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes.
Wadowski PP; Weikert C; Pultar J; Lee S; Eichelberger B; Koppensteiner R; Lang IM; Panzer S; Gremmel T
Cardiovasc Drugs Ther; 2020 Feb; 34(1):53-63. PubMed ID: 32062795
[TBL] [Abstract][Full Text] [Related]
18. Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Transl Res; 2013 May; 161(5):421-9. PubMed ID: 23340049
[TBL] [Abstract][Full Text] [Related]
19. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo.
Gries A; Bode C; Peter K; Herr A; Böhrer H; Motsch J; Martin E
Circulation; 1998 Apr; 97(15):1481-7. PubMed ID: 9576429
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity.
Yang YM; Wang XX; Chen JZ; Wang SJ; Hu H; Wang HQ
Am J Chin Med; 2008; 36(3):603-13. PubMed ID: 18543392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
